Pfizer’s First COVID-19 Vaccine Results Might Be Just Days Away - But Patience Could Pay Off
Operation Warp Speed Leader Says Early Data Will Be Slim
Executive Summary
Analysts are confident that Pfizer/BioNTech’s mRNA vaccine will prove its safety and efficacy – but waiting a little longer for more robust data could be for the best.
You may also be interested in...
Quick Listen: Scrip’s Five Must-Know Things
Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Coronavirus Update: After FDA Sneaks Out Guidance, Trump’s Vaccine Dream Is Over
After threats to overrule the agency, the Trump administration has indicated that the stricter guidance will be allowed to stand.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.